Méndez-Tovar LJ, Manzano-Gayosso P, Cumplido-Uribe C, Hernández-Hernández F, Ramos-Hernández J, López-Martínez R

Language: Spanish
References: 29
Page: 609-614
PDF size: 60.83 Kb.

ABSTRACT

Background: fungal invasive infections are frequent in patients with immunosuppression. A common clinical feature is the presence of fever of unknown origin (FUO) in any of its several presentations. The aim of this study was to know the frequency of FUO associated to invasive mycosis in hospitalized patients.
Methods: samples from 34 patients were studied by immunological and microbiological procedures in order to investigate candidiasis, cryptococcosis, aspergillosis and Pneumocystis infection.
Results: fungal infection diagnosis was established in 12 (35 %) from 34 patients who full criterion. The fungal species isolated were Candida albicans (six), Aspergillus fumigates (four) and Cryptococcus sp. (two). All candidiasis cases were diagnosed only by microbiological studies, aspergillosis by immunological and microbiological studies, and cryptococcosis only by immunological studies.
Conclusions: we concluded that is important the searching of mycosis in immunocompromised patients with fever of unknown origin by microbiological and immunological procedures.

REFERENCES

1. Lockhart SR, Diekema DJ, Pfaller MA. The epidemiology of fungal infections. En: Anaissie EJ, McGinnis MR, Pfaller MA, editores. Clinical mycology. United Kingdom: Elsevier; 2009. p. 1-14.

2. Baer SL, Pappas PG. Hematogenously disseminated fungal infections. En: Anaissie EJ, McGinnis MR, Pfaller MA, editores. Clinical mycology. United Kingdom: Elsevier; 2009. p. 609-622.

3. López-Martínez R. Introducción. Importancia actual de la micología médica en México. Gac Med Mex 2008;144 (2):121-122.

4. Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis and management. Clin Infect Dis 1993;17 (Suppl 2):S487-S491.

5. Einollahi B, Lessan-Pezeshki M, Pourfarziani V, Nemati E, Nafar M, Pour-Reza-Gholi F, et al. Invasive fungal infections following renal transplantation: a review of 2410 recipients. Ann Transplant 2008;13(4):55-58.

6. García-Ruiz JC. Micosis en los pacientes hematológicos. Rev Iberoam Micol 2002;19:13-16.

7. Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006; 43(Suppl 1):S3-14.

8. Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am 2007;21(3):617-638vii.

9. Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002;34(8):1098-1107.

10. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007;20(1):133-163.

11. Singh N. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis 2001;33(10):1692-1696. Epub 2001 Oct 12.

12. Bava AJ, Robles AM, Negroni R, Arechavala A, Bianchi M. Estudio de algunos aspectos epidemiológicos de 253 casos de criptococosis. Rev Iberoam Micol 1997;14: 111-114.

13. Wissmann G, Morilla R, Friaza V, Calderón E, Varela JM. El ser humano como reservorio de Pneumocystis. Enferm Infecc Microbiol Clin 2010;28(1):38-43.

14. Méndez-Tovar LJ, Ramos-Hernández JM, Manzano- Gayosso P, García-González A, Hernández-Hernández F, Bazán-Mora E, et al. Micosis sistémicas: experiencia de once años en el Hospital de Especialidades del Centro Médico Nacional Siglo XXI del IMSS, México. Rev Mex Micol 2007;25:15-19.

15. Knockaert DC. Recurrent fevers of unknown origin. Infect Dis Clin North Am 2007;21(4):1189-1211.

16. Durack DT, Street AC. Fever of unknown origin: reexamined and redefined. Curr Clin Top Infect Dis 1991;11:35-51.

17. Knocakaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 1992;152(1):51-55.

18. deKleijn EM, Vandenbroucke JP, van der Meer J; The Netherlands FUO Study Group. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine (Baltimore) 1997;76(6):392-400.

19. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999;28(5):1071-1079.

20. Chow A, Robinson JL. Fever of unknown origin in children: a systematic review. World J Pediatr 2011;7(1):5-10.

21. Cagatay AA, Tufan F, Hindilerden F, Aydin S, Elcioglu OC, Karadeniz A, et al. The causes of acute fever requiring hospitalization in geriatric patients: comparison of infectious and noninfectious etiology. J Aging Res 2010;2010: doi:10.40612010/380892.

22. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007;20(1):133-163.

23. Gutiérrez J, Maroto C, Piédrola G, Martín E, Pérez JA. Circulating Candida antigens andantibodies: useful markers of candidemia. J Clin Microbiol 1993;31(9):2550-2552.

24. Sendid B, Caillot D, Baccouch-Humbert B, Klingspor L, Grandjean M, Bonnin A, et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 2003;41(10):4551-4558.

25. Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009;58(Pt 5):606-615.

26. Soki H, Nagase Y, Yamazaki K, Oda T, Kikuchi K. Isolation of the yeast-like fungus Stephanoascus ciferrii by culturing the aural discharge of a patient with intractable otitis media. Case report. Kansenshogaku Zasshi 2010;84(2):210-212.

27. Kronstad JW, Attarian R, Cadieux B, Choi J, D’Souza CH, Griffiths EJ. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nature Rev Microbiol 2011;9(3):193-203.

28. Cooper EE, O’Reilly MA, Guest DI, Dharmage SC. Influence of building construction work on Aspergillus infection in a hospital setting. Infect Control Hosp Epidemiol 2003;24 (7):472-476.

29. Raviv Y, Kramer MR, Amital A, Rubinovitch B, Bishara J, Shitrit D. Outbreak of aspergillosis infections among lung transplant recipients. Traspl Int 2007;20(2):135-140.